BOAOXIN
Biosion is a biotech company focused on the development of biologics to treat resistant, relapsed, residual immune, and oncologic diseases.
BOAOXIN
Social Links:
Industry:
Biopharma Biotechnology Medical Medical Device
Founded:
2017-01-01
Address:
Nanjing, Jiangsu, China
Country:
China
Website Url:
http://www.biosion.com
Total Employee:
51+
Status:
Active
Contact:
+86-25-5829-1977
Email Addresses:
[email protected]
Total Funding:
200 M CNY
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Asklepios BioPharmaceutical
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.
BioTreat21
Biotreat 21 invents a cream intended to regrow damaged skin completely by utilizing the individual’s own immune system.
Pilot Biotechnology
Pilot Biotechnology is an industrial biotechnology company engaged in the development, production, and sales of health care products.
Sinocelltech
Sinocelltech is a biotech company that develops and manufactures recombinant proteins, monoclonal antibodies, and vaccines.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Sunshine Biopharma
Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer.
Current Advisors List
Current Employees Featured
Investors List
3E Bioventures
3E Bioventures investment in Venture Round - Boaoxin
Official Site Inspections
http://www.biosion.com
- Host name: 202.102.90.93
- IP address: 202.102.90.93
- Location: China
- Latitude: 32.0617
- Longitude: 118.7778
- Timezone: Asia/Shanghai
More informations about "Boaoxin"
Biosion
Biosion is a clinical-stage biotechnology company committed to developing breakthrough antibody-based therapies to improve patient outcomes for the treatment of immune and …See details»
Biosion - Crunchbase Company Profile & Funding
Biosion is a global R&D biotechnology company committed to developing antibody-based therapies to improve patient outcomes for the treatment of immune and oncologic diseases. …See details»
Biosion Company Profile 2024: Valuation, Funding & Investors
Biosion General Information Description. Researcher and developer of biomedical drugs designed for the treatment of immune and oncologic diseases. The company's antibody-based therapies …See details»
Biosion - LinkedIn
Biosion is a global R&D biotechnology company committed to developing antibody-based therapies to improve patient outcomes for the treatment of immune and oncologic diseases.See details»
Biosion Announces Exclusive, Global License Agreement with …
Nov 18, 2024 Biosion, Inc. (Biosion), a global R&D stage biotechnology company, today announced that it has entered into an exclusive license agreement with Aclaris Therapeutics …See details»
Biosion | LinkedIn
Biosion | 704 followers on LinkedIn. Delivering breakthrough therapeutics to patients globally | Biosion is a global R&D biotechnology company committed to developing antibody-based …See details»
Biosion - Products, Competitors, Financials, Employees, …
Biosion engages in global partnerships to maximize the value of its portfolio. It was founded in 2017 and is based in Nanjing, Jiangsu. Headquarters Location. Longshan South Road, …See details»
Biosion, Inc. Completed Pre-B+ Round Financing to Accelerate the ...
Dec 10, 2021 New funding will strengthen Biosion’s “In Global For Global” positioning by accelerating its clinical pipeline and expanding its global biologics development teams Newark, …See details»
Biosion, Inc. - BIO International Convention | BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... Biosion's lead asset, BSI-045B …See details»
Biosion, Inc | Insights
May 16, 2024 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
BIOSION, INC. Top 13F Holdings - WhaleWisdom.com
5 days ago BIOSION, INC. 5TH FLOOR, BUILDING D NANJING F4 210061 Business Phone: 267-356-9574. SEC SIC CODE: 2834-PHARMACEUTICAL PREPARATIONS Recent SEC …See details»
Aclaris Therapeutics secures global rights to Biosion’s antibodies
Nov 19, 2024 Aclaris Therapeutics has secured an exclusive licence from Biosion for the global rights to two new antibodies, BSI-045B and BSI-502, excluding Greater China. Biosion will be …See details»
Biosion Announces Exclusive, Global License Agreement with …
Nov 18, 2024 Biosion is a global clinical-stage biotechnology company focused on developing innovative antibody-based therapies to improve outcomes for patients with immune and …See details»
Biosion - 关于博奥信
博奥信宣布与Aclaris Therapeutics就两项潜在的同类首创和同类最佳免疫药物资产达成全球独家授权许可协议. 2024-11-18. 博奥信被认定为国家级专精特新“小巨人”企业. 2024-09-02. 博奥信合 …See details»
Biosion
Biosion scientists believe that great medicines come from the synergy of great science, cutting-edge technologies, and superior craftmanship. DRUG DESIGN IS FUNDAMENTAL TO …See details»
Biosion: Home
About us ... scienceSee details»
Boaoxin - Crunchbase Company Profile & Funding
Organization. Boaoxin . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Contact Email [email protected]; Phone …See details»
Biosion
Biosion’s Right Modality / Target Indication Development Stage Partner Preclinical IND Phase I Phase II BSI-045B Ex China TSLP Auto-immune BSI-038 Ex China CD40 Solid Tumors BSI …See details»
Biosion
Biosion has developed a proprietary, state-of-the-art platform called H 3 Antibody Technology that enables discovery of multiple therapeutic candidates with superior properties High-Throughput …See details»